Clinical Drug Experience Knowledgebase

atezolizumab (Tecentriq) (1 trial)

binimetinib (mektovi) (1 trial)

cemiplimab (libtayo) (1 trial)

cobimetinib (cotellic) (2 trials)

dabrafenib (tafinlar) (1 trial)

encorafenib (braftovi) (1 trial)

interferon alpha-2b (Intron-A) (1 trial)

ipilimumab (yervoy) (1 trial)

nivolumab (opdivo) (1 trial)

trametinib (mekinist) (1 trial)

vemurafenib (zelboraf) (3 trials)